# Peter Lio

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-lio/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,754 |
| Field | Dermatology and Skin Diseases |
| h-index | 42 |
| i10-index | 119 |
| Last Known Institution | Northwestern University |
| OpenAlex ID | https://openalex.org/A5043201259 |
| ORCID iD | 0000-0001-7600-0152 |
| Works | 428 |

## Researcher papers

- [Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-upadacitinib-vs-dupilumab-in-adults-with-moderate-to/)
- [Atopic dermatitis: A practice parameter update 2012](https://scholariq.org/papers/atopic-dermatitis-a-practice-parameter-update-2012/)
- [Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations](https://scholariq.org/papers/atopic-dermatitis-eczema-guidelines-2023-american-academy-of-allergy-asthma-and/)
- [Activation and Habituation in Olfaction—An fMRI Study](https://scholariq.org/papers/activation-and-habituation-in-olfaction-an-fmri-study/)
- [A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses](https://scholariq.org/papers/a-systematic-review-of-topical-corticosteroid-withdrawal-steroid-addiction-in/)
- [The Skin Barrier and Moisturization: Function, Disruption, and Mechanisms of Repair](https://scholariq.org/papers/the-skin-barrier-and-moisturization-function-disruption-and-mechanisms-of-repair/)
- [Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials](https://scholariq.org/papers/systemic-treatments-for-atopic-dermatitis-eczema-systematic-review-and-network/)
- [Risk Factors for Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis](https://scholariq.org/papers/risk-factors-for-dupilumab-associated-conjunctivitis-in-patients-with-atopic/)
- [Online video improves clinical outcomes in adults with atopic dermatitis: A randomized controlled trial](https://scholariq.org/papers/online-video-improves-clinical-outcomes-in-adults-with-atopic-dermatitis-a/)
- [Hair Growth in Two Alopecia Patients after Fecal Microbiota Transplant](https://scholariq.org/papers/hair-growth-in-two-alopecia-patients-after-fecal-microbiota-transplant/)
- [Healthcare Resource Utilization and Economic Burden Across Clinical Phenotypes of Moderate-to-Severe Atopic Dermatitis in United States Dermatology Facilities](https://scholariq.org/papers/healthcare-resource-utilization-and-economic-burden-across-clinical-phenotypes/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Researcher university

- [Northwestern University](https://scholariq.org/institutions/northwestern-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.